Suppr超能文献

[如何区分常染色体显性遗传性视神经萎缩和Leber遗传性视神经病变]

[How to distinguish between autosomal dominant optic atrophy and Leber's hereditary optic neuropathy].

作者信息

Leo-Kottler B, Jägle H, Küpker T, Schimpf S

机构信息

Universitätsaugenklinik, Schleichstrasse 12-16, 72076 Tübingen.

出版信息

Ophthalmologe. 2007 Dec;104(12):1060-5. doi: 10.1007/s00347-007-1577-y.

Abstract

BACKGROUND

Patients with long-lasting bilateral optic atrophy showed typical clinical features of autosomal dominant optic atrophy (ADOA). Molecular genetic analysis identified them as atypical cases of Leber's hereditary optic neuropathy (LHON).

METHOD

Three patients with bilateral optic atrophy and central scotomas of their visual fields were clinically diagnosed with ADOA. Samples of lymphocytic genomic DNA were amplified with polymerase chain reaction, and analysis of the coding exons including the flanking intron/UTR sequences of the OPA-1 gene was performed. However, no ADOA-associated mutations were found. We therefore analysed the total lymphocyte mitochondrial DNA for all common LHON mutations in these patients.

RESULTS

Three patients from three unrelated pedigrees (two men, one woman) who were clinically diagnosed as suffering from ADOA did not harbor any typical mutation of the OPA-1 gene. However, analysis of their mitochondrial DNA showed that they harbored the 3460, 11778, and 14484 LHON mutations. The patients were identified as atypical cases of LHON. The pedigrees of the patients fulfilled the criteria for both dominant and mitochondrial-maternal transmission in all cases. The clinical picture of LHON differed remarkably from the classic course of LHON.

CONCLUSIONS

To identify atypical LHON patients with bilateral optic atrophy and central scotomas in the visual field and to distinguish them from ADOA patients, careful molecular genetic analysis is necessary. In these rare cases, only double examinations of both the genomic and the mitochondrial DNA will allow these patients to be adequately advised.

摘要

背景

患有长期双侧视神经萎缩的患者表现出常染色体显性视神经萎缩(ADOA)的典型临床特征。分子遗传学分析将他们鉴定为Leber遗传性视神经病变(LHON)的非典型病例。

方法

三名患有双侧视神经萎缩且视野中有中心暗点的患者在临床上被诊断为ADOA。淋巴细胞基因组DNA样本通过聚合酶链反应进行扩增,并对OPA-1基因的编码外显子包括侧翼内含子/UTR序列进行分析。然而,未发现与ADOA相关的突变。因此,我们分析了这些患者全部淋巴细胞线粒体DNA中的所有常见LHON突变。

结果

来自三个无亲缘关系家系的三名患者(两名男性,一名女性),临床上诊断为患有ADOA,未携带OPA-1基因的任何典型突变。然而,对其线粒体DNA的分析表明,他们携带3460、11778和14484 LHON突变。这些患者被鉴定为LHON的非典型病例。所有病例中患者的家系均符合显性和线粒体母系遗传的标准。LHON的临床症状与LHON的经典病程明显不同。

结论

为了识别视野中有双侧视神经萎缩和中心暗点的非典型LHON患者,并将他们与ADOA患者区分开来,需要进行仔细的分子遗传学分析。在这些罕见病例中,只有对基因组DNA和线粒体DNA进行双重检测,才能为这些患者提供充分的建议。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验